Guidance
Measles and Measles-Rubella (MR) Vaccine Five-Dose Vial Presentation - Fact Sheet 2022 - 2023
Compiled UNICEF and WHO insights on the 5-dose presentation (e.g., estimated reductions in wastage, estimated required cold storage).
Languages
- English
Publication year
2022
Type
Guidance
Categories
- Service delivery
Diseases
- Measles
Organisations
- United Nations Children's Fund (UNICEF)
Tags
- Missed opportunities for vaccination (MOV)
- Optimize
- Vaccine presentation and packaging
- Wastage
MCV5 PHASE 1
You can find more information about "MCV5 PHASE 1" in the following Hot Topics:
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Measles and Measles-Rubella (MR) Vaccine Five-Dose Vial Presentation - Fact Sheet 2022 - 2023 | UNICEF, World Health Organization (WHO) | 2022 | Guidance | English |
| MCV 5-dose Research and Resources | Linksbridge | 2022 | Report | English |
| MCV 5-dose National Impact Assessment Tool | Linksbridge | 2026 | Tool | English, French |
| Experiences with the MCV 5-dose Switch from Africa’s EPI | UNICEF | 2024 | Case study | English |
| How To Use: Step-by-Step Instructions for the MCV 5-dose National Impact Assessment Tool | Linksbridge | 2025 | User guide | English |
| MCV 5-dose Option Overview | Linksbridge | 2026 | Guidance | English |
| MCV 5-dose 2-Pager | Linksbridge | 2026 | Guidance | English |
